- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Legend Biotech achieves $487m IPO
Genscript Biotech's multiple myeloma-focused spinoff, which counts Eli Lilly and Johnson & Johnson among its investors, has completed an initial public offering in the US.
Jun 10, 2020Evox engineers $10m from Eli Lilly
Eli Lilly will collaborate on five drug candidates based on the Oxford and Karolinska Institute spinout's exosome delivery technology.
Jun 10, 2020Snowflake to crystallise IPO plans
Capital One and Salesforce-backed cloud database provider Snowflake has confidentially filed for an initial public offering that could value it at up to $20bn.
Jun 10, 2020RWS sweeps up Iconic Translation Machines
RWS Holdings had bought language translation software developer Iconic Translation Machines, founded on DCU's research into translating patents.
Jun 10, 2020DNAnexus ties up $100m
Existing backer GV returned to take part in a $100m round for the clinical data software provider that also attracted new investor Regeneron Pharmaceuticals.
Jun 10, 2020Fusion Pharmaceuticals to mingle with public markets
Johnson & Johnson and Varian Medical Systems are in line for exits after cancer therapy developer Fusion filed for a $100m initial public offering.
Jun 10, 2020ArcherDX takes bow for $100m IPO
The cancer diagnostics technology developer, formed five years ago when Qiagen acquired part of Enzymatics, has filed to float on the Nasdaq Global Market.
Jun 10, 2020HistoSonics beams in $40m
Varian Medical Systems and Johnson & Johnson Innovation – JJDC returned for the series C-1 round having backed the histotripsy technology developer's series C last year.
Jun 10, 2020Saudi Aramco helps finance $25m round for Wahed
The Sharia-compliant wealth management service raised the cash in a round co-led by Saudi Aramco Entrepreneurship Ventures.
Jun 10, 2020Propzy cops $25m in series A round
The real estate services portal increased its overall funding to $37m with a round co-led by SoftBank Ventures Asia that also featured RSquare.
Jun 10, 2020Fusion to mingle with public markets
McMaster University spinout Fusion Pharmaceuticals has filed for a $100m IPO in the US, putting shareholders such as Facit in line for exits.
Jun 10, 2020UCloudlink reaches IPO heights
Cash Capital has celebrated an exit as UCloudlink raised $36.2m in its offering, after pricing its shares at the bottom of the range and issuing less stock than originally planned.
Jun 9, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
